Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koehler Pharmaceutical Asia is the regional subsidiary of Dr. Franz Köhler Chemie GmbH, a German pharmaceutical company specializing in organ protection and preservation solutions. The company is primarily recognized for its flagship product, Custodiol HTK, which is a gold-standard solution used globally for cardioplegia and the preservation of organs such as the heart, kidney, liver, and lung during transplantation. Based in Singapore, the Asian entity facilitates the distribution and clinical support of these life-saving products across the Asia-Pacific region. In addition to organ preservation, the company offers specialized pharmaceuticals for intensive care, anesthesia, and emergency medicine. Their focus remains on improving surgical outcomes and extending the viability of donor organs through advanced electrolyte-based formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koehler Pharmaceutical Asia.